Background: Patients with left ventricular (LV) systolic dysfunction have an increased risk for
ventricular arrhythmias. Purpose: To summarize the evidence about benefits and harms of …

Background—Several studies that used claims and registry data have reported that 40% to
80% of patients eligible for an implantable cardioverter defibrillator (ICD) fail to receive one …

BACKGROUND: Clinical guidelines recommend implantable cardioverter-defibrillators
(ICDs) for selected patients with chronic left ventricular dysfunction (LVD) to improve …

Background—Implantable cardioverter-defibrillators (ICDs) improve survival in selected
patients with left ventricular systolic dysfunction in randomized trials. Competing death …

Importance Improvement in left ventricular ejection fraction (EF) to> 35% occurs in many
patients with reduced EF at baseline. To our knowledge, whether implantable cardioverter …

Background—Although implantable cardioverter-defibrillators (ICDs) reduce mortality in
primary prevention patients with left ventricular systolic dysfunction, recent studies have …

The implantable cardioverter defibrillator (ICD) has emerged as an important treatment
option for selected patients who are at risk of sudden cardiac death. Randomized trials have …

Aims Primary prevention implantable cardioverter defibrillators (ICDs) are established
therapy for reducing mortality in patients with left ventricular systolic dysfunction and …

Background: The DANISH study (Danish Study to Assess the Efficacy of ICDs [Implantable
Cardioverter Defibrillators] in Patients With Non-Ischemic Systolic Heart Failure on Mortality) …

Background—The clinical effectiveness of implantable cardioverter-defibrillators (ICDs) in
older patients with heart failure has not been established, and older patients have been …